Loraz and Claritin-d drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Claritin-d (loratadine; pseudoephedrine sulfate). Common drug interactions include dyspnoea among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Claritin-d. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Claritin-d?

Claritin-d has active ingredients of loratadine; pseudoephedrine sulfate. It is often used in allergies. eHealthMe is studying from 7,055 Claritin-d users. Check the latest studies of Claritin-d.



On Jul, 06, 2026

56 people who take Loraz and Claritin-d together, and have interactions are studied.

Loraz and Claritin-d drug interactions.

What are the common drug interactions of Loraz and Claritin-D, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fall
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Hepatic steatosis (fatty liver disease)
  5. Hypersensitivity
  6. Hypertension (high blood pressure)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Injection site erythema (redness at injection site)
  9. Injection site pain
  10. Injection site swelling

male:

  1. Asthenia (weakness)
  2. Fatigue (feeling of tiredness)
  3. Weight increased
  4. Blood albumin decreased
  5. Blood glucose increased
  6. Blood pressure increased
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Disease progression
  9. Dry skin
  10. Dyspepsia (indigestion)

What are the common drug interactions of Loraz and Claritin-D, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Herpes simplex (herpes simplex is a common viral infection)
  2. Anaemia (lack of blood)
  3. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  4. Muscle twitching
  5. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

40-49:

  1. Psoriasis (immune-mediated disease that affects the skin)
  2. Road traffic accident
  3. Skin exfoliation (removal of the oldest dead skin cells)
  4. Skin lesion
  5. Back pain
  6. Clavicle fracture
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Dry skin
  9. Febrile neutropenia (fever with reduced white blood cells)
  10. Injection site erythema (redness at injection site)

50-59:

  1. Oral candidiasis (fungal infection of mouth)
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Death
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Panophthalmitis (inflammation of all the eye structures or tissues)
  6. Streptococcal sepsis (whole body inflammation by streptococcal)
  7. Eye pruritus (eye itching)
  8. Lacrimation increased
  9. Rhinorrhoea (watery mucus discharge from the nose)
  10. Blood creatine phosphokinase increased

60+:

  1. Fatigue (feeling of tiredness)
  2. Asthenia (weakness)
  3. Chest pain
  4. Pain in extremity
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Visual impairment
  7. Blood albumin decreased
  8. Blood glucose increased
  9. Blood pressure increased
  10. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 12 people, 21.43%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 19.64%
  3. Nausea (feeling of having an urge to vomit): 10 people, 17.86%
  4. Depression: 10 people, 17.86%
  5. Multiple Myeloma (cancer of the plasma cells): 10 people, 17.86%
  6. Seasonal Allergy (allergic condition due to certain season): 9 people, 16.07%
  7. Pain: 9 people, 16.07%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 14.29%
  9. Hypersensitivity: 8 people, 14.29%
  10. Upper Respiratory Tract Infection: 5 people, 8.93%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Claritin-d?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Loraz and Claritin-d:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Loraz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Claritin-d:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Loraz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Claritin-d and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lorazepam and loratadine; pseudoephedrine sulfate (the active ingredients of Loraz and Claritin-d, respectively), and Loraz and Claritin-d (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: